Postech Academy-industry Foundation

Posco

Postech Foundation

Pohang University of Science and Technology Foundation

Novacell Technology Inc.

Taehoon Lee

Pann-Ghill Suh

Sung-Ho Ryu

Sung Ho Ryu

Yoe-Sik Bae

Youn-Dong Kim

Eun-Mi Hur

Yong-Soo Park

Yun-Hee Kim

Kyong-Tai Kim

You-Suk Seo

Byoung Dae Lee

Young-Chul Sung

SooMi Kim

The present application discloses angiogenic peptides that cause intracellular calcium release in target cells and thereby induce proliferation, migration, and capillary-like tube formation in primary cultured endothelial cells. The angiogenic peptides can be used for preventing and/or treating angiognesis-related conditions, especially wound healing, treating foot and leg ulcers in a subject, etc. In addition, the angiogenic peptides can be used for cosmetics a constituent of cosmetics for aged skin, for examples, anti-wrinkle and skin whitening.

Angiogenic peptide

The present invention relates to a method of protecting cells against damage caused at least in part by apoptosis, comprising administering to subjects a therapeutic dose of leumorphin having cytoprotective activity, and a pharmaceutical composition comprising an effective amount of leumorphin having a cytoprotective activity.

Method of protecting cells against damage and pharmaceutical composition comprising leumorphin

A vaccine having a good vaccination effect, which comprises an antigen; a peptide selected from the group consisting of a peptide having the amino acid sequence of SEQ ID NO: 1, a peptide having the amino acid sequence of SEQ ID NO: 2, and a peptide derived from a peptide having the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2; and an immune activator.

Vaccine composition containing a promoter peptide

Growing community of inventors

Pohang, South Korea

Taehoon Lee